Merck KGaA
MIL:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck KGaA
MIL:MRK
|
DE |
|
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
US |
|
H
|
Healthcare Services Group Inc
F:HS1
|
US |
|
D
|
DBS Group Holdings Ltd
XBER:DEVL
|
SG |
|
S
|
Safran SA
F:SEJ1
|
FR |
|
ESR-REIT
F:UZ00
|
SG |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
|
A
|
Azimut Holding SpA
XMUN:HDB
|
IT |
|
F
|
Fairvest Ltd
JSE:FTB
|
ZA |
|
Atoss Software AG
F:AOF
|
DE |
|
M
|
Marks and Spencer Group PLC
DUS:MA6
|
UK |
|
UniCredit SpA
F:CRIN
|
IT |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
Wall St Price Targets
MRK Price Targets Summary
Merck KGaA
According to Wall Street analysts, the average 1-year price target for MRK is 159.14 EUR with a low forecast of 127.3 EUR and a high forecast of 204.21 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRK's stock price target?
Price Target
159.14
EUR
According to Wall Street analysts, the average 1-year price target for MRK is 159.14 EUR with a low forecast of 127.3 EUR and a high forecast of 204.21 EUR.
What is the Revenue forecast for Merck KGaA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Merck KGaA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Merck KGaA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Merck KGaA?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Merck KGaA?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 17%.
